Barclays’s Aehr Test Systems AEHR Stock Holding History

Barclays’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-211,800	Closed	-$4.26M	–	5064
2022 Q4	$4.26M	Buy	+211,800	New	+$4.53M	﹤0.01%	1739

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays's AEHR Position: Q2 2026 in Review

Barclays increased its Aehr Test Systems (AEHR) stake by 94% in Q2 2026, buying an estimated $4.48M and bringing the position to 101,249 shares worth $9.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1493.

Barclays first reported a position in AEHR in Q3 2021 and has held it in 18 quarters since. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Barclays held 101,249 shares of Aehr Test Systems worth $9.73M as of Q2 2026.
Barclays bought 49,035 Aehr Test Systems shares in Q2 2026, an estimated $4.48M.
Aehr Test Systems made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1493 holding.
Barclays first reported a position in Aehr Test Systems in Q3 2021 and has held it in 18 quarters since.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.